[1] Octave JN. The amyloid peptide precursor in Alzheimer’s disease [J]. Acta Neurol Belg, 1995, 95(4): 197-209. [2] Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE[J]. Science, 1999, 286(5431): 735-41. [3] Paresce DM, Ghosh RN, Maxfield FR, et al. Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor[J]. Neuron, 1996, 17(4): 553-65. [4] Jungblut PR, Zimny AU, Zeindl EE, et al. Proteomics in human disease: cancer, heart and infectious diseases [J]. Electrophoresis, 1999,20(10): 2100-10. [5] Dongre AR, Opiteck G, Cosand WL, et al. Proteomics in the postgenome age [J]. Biopolymers, 2001, 60(3): 206-11. [6] 周思朗,陈俊抛,涂晓文,等.碱性成纤维细胞生长因子对阿尔茨海默病模型大鼠的影响[J].第一军医大学学报,2003,23(6):611-3.Zhou SL, Chen JP, Tu XW, et al. Effects of basic fibroblast growth factor on rat models of Alzheimer disease [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(6): 611-3. [7] 刘辉,陈俊抛,田时雨,等海马注射β淀粉样蛋白对大鼠学习记忆及局部神经元的损伤作用[J].中华神经科杂志,2000,33(3):150-2.Liu H, Chen JP, Tian SY, et al. Intrahippocampal injection of β amyloidl-40 induces neurotoxicity in rats in vivo[J]. Chin J Neurol,2000, 33(3): 150-2. [8] Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding[J]. Anal Biochem, 1976, 72: 248-54. [9] Gorg A, Obermaier C, Boguth G, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients [J]. Electrophoresis, 2000, 21(6): 1037-53. [10] Greber S, Lubec G, Cairns N, et al. Decreased levels of synaptosomai associated protein 25 in the brain of patients with Down syndrome and Alzheimer’s disease [J]. Electrophoresis, 1999, 20(4-5):928-34. [11] Rachel Z, Albert P, Edgar G, et al. Cloning and characterization of the human activity-dependent neuroprotective protein [J]. J Biol Chem, 2001, 276(1): 708-14. |